The Costly Alzheimer's Consequence

This chapter delves into the escalating Medicare costs projected for Alzheimer's patients, expected to reach $453 billion by 2050, while also addressing the impact of recent layoffs at a prominent Alzheimer's research center. Additionally, it scrutinizes claims by Doge about significant taxpayer savings, revealing inconsistencies and errors in the data that challenge the credibility of these assertions.